| Aktienanzahl | 25,73 Mio. |
| Aktientyp | Stammaktie |
China New Borun Corp (NASDAQ:BORN) was upgraded by ING Group from a "hold" rating to a "buy" rating in a research note issued on Monday.
The analysts wrote, "China New Borun (BORN) has been upgraded by TheStreet Ratings from hold to buy. The company"s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and growth in earnings per share...
China New Borun Corp (NASDAQ:BORN) traded down 11.01% on Monday, hitting $2.83. 798,874 shares of the company"s stock traded hands. China New Borun Corp has a 52-week low of $1.11 and a 52-week high of $4.40. The stock has a 50-day moving average of $2.74 and a 200-day moving average of $2.54. The company has a market cap of $72.8 million and a P/E ratio of 4.81. China New Borun Corp (NASDAQ:BORN) last announced its earnings results on Wednesday, March 5th. The company reported $0.19 EPS for the quarter. The company had revenue of $107.90 million for the quarter.
http://www.wkrb13.com/markets/313550/china-new-borun-corp-upgraded-to-buy-by-ing-group-born/
Ansonsten ist wohl spätestens 30 Tage vor den nächsten Zahlen wieder ein guter Zeitpunkt einzusteigen/nachzulegen. Außerdem erwarte ich jederzeit die Meldung, dass BORN Zulieferer der Chinesischen Medizin sein wird.
Der Weg nach oben ist noch lang...